TY  - GEN
AU  - Fabris,M
AU  - Quartuccio,L
AU  - Fabro,C
AU  - Sacco,S
AU  - Lombardi,S
AU  - Ramonda,R
AU  - Biasi,D
AU  - Punzi,D
AU  - Adami,S
AU  - Olivieri,I
AU  - Curcio,F
AU  - De Vita,S
TI  - The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis
SN  - 1473-1150
PY  - 2017///0309
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antirheumatic Agents
KW  - adverse effects
KW  - Biological Products
KW  - Chi-Square Distribution
KW  - Drug Substitution
KW  - Female
KW  - Genetic Association Studies
KW  - Homozygote
KW  - Humans
KW  - Interleukin-6
KW  - genetics
KW  - Italy
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Odds Ratio
KW  - Pharmacogenomic Testing
KW  - Pharmacogenomic Variants
KW  - Phenotype
KW  - Polymorphism, Single Nucleotide
KW  - Predictive Value of Tests
KW  - Promoter Regions, Genetic
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sex Factors
KW  - Spondylarthritis
KW  - blood
KW  - Time Factors
KW  - Treatment Failure
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1038/tpj.2015.49
ER  -